1. (1988) Bombesin-like peptides in health and disease. Proceedings of an international symposium. October 13-16, 1987, Rome, Italy. A tribute to Vittorio Erspamer, M.D.
Ann N Y Acad Sci, 547: 1-541.
[PMID:3071214]
2. Barak, Y; Nelson, MC; Ong, ES; Jones, YZ; Ruiz-Lozano, P; Chien, KR; Koder, A; Evans, RM. (1999) PPAR gamma is required for placental, cardiac, and adipose tissue development.
Mol. Cell, 4 (4): 585-95.
[PMID:10549290]
3. Barroso, I; Gurnell, M; Crowley, VE; Agostini, M; Schwabe, JW; Soos, MA; Maslen, GL; Williams, TD; Lewis, H; Schafer, AJ; Chatterjee, VK; O'Rahilly, S. (1999) Dominant negative mutations in human PPARgamma associated with severe insulin resistance, diabetes mellitus and hypertension.
Nature, 402 (6764): 880-3.
[PMID:10622252]
4. Beamer, BA; Yen, CJ; Andersen, RE; Muller, D; Elahi, D; Cheskin, LJ; Andres, R; Roth, J; Shuldiner, AR. (1998) Association of the Pro12Ala variant in the peroxisome proliferator-activated receptor-gamma2 gene with obesity in two Caucasian populations.
Diabetes, 47 (11): 1806-8.
[PMID:9792554]
5. Berger, J; Bailey, P; Biswas, C; Cullinan, CA; Doebber, TW; Hayes, NS; Saperstein, R; Smith, RG; Leibowitz, MD. (1996) Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-gamma: binding and activation correlate with antidiabetic actions in db/db mice.
Endocrinology, 137 (10): 4189-95.
[PMID:8828476]
6. Berger, J; Leibowitz, MD; Doebber, TW; Elbrecht, A; Zhang, B; Zhou, G; Biswas, C; Cullinan, CA; Hayes, NS; Li, Y; Tanen, M; Ventre, J; Wu, MS; Berger, GD; Mosley, R; Marquis, R; Santini, C; Sahoo, SP; Tolman, RL; Smith, RG; Moller, DE. (1999) Novel peroxisome proliferator-activated receptor (PPAR) gamma and PPARdelta ligands produce distinct biological effects.
J. Biol. Chem., 274 (10): 6718-25.
[PMID:10037770]
7. Berger, JP; Petro, AE; Macnaul, KL; Kelly, LJ; Zhang, BB; Richards, K; Elbrecht, A; Johnson, BA; Zhou, G; Doebber, TW; Biswas, C; Parikh, M; Sharma, N; Tanen, MR; Thompson, GM; Ventre, J; Adams, AD; Mosley, R; Surwit, RS; Moller, DE. (2003) Distinct properties and advantages of a novel peroxisome proliferator-activated protein [gamma] selective modulator.
Mol. Endocrinol., 17 (4): 662-76.
[PMID:12554792]
8. Bishop-Bailey, D; Hla, T; Warner, TD. (2000) Bisphenol A diglycidyl ether (BADGE) is a PPARgamma agonist in an ECV304 cell line.
Br. J. Pharmacol., 131 (4): 651-4.
[PMID:11030710]
9. Brooks, DA; Etgen, GJ; Rito, CJ; Shuker, AJ; Dominianni, SJ; Warshawsky, AM; Ardecky, R; Paterniti, JR; Tyhonas, J; Karanewsky, DS; Kauffman, RF; Broderick, CL; Oldham, BA; Montrose-Rafizadeh, C; Winneroski, LL; Faul, MM; McCarthy, JR. (2001) Design and synthesis of 2-methyl-2-[4-(2-[5-methyl-2-aryloxazol-4-yl]ethoxy)phenoxy]propionic acids: a new class of dual PPARalpha/gamma agonists.
J. Med. Chem., 44 (13): 2061-4.
[PMID:11405642]
10. Brown, KK; Henke, BR; Blanchard, SG; Cobb, JE; Mook, R; Kaldor, I; Kliewer, SA; Lehmann, JM; Lenhard, JM; Harrington, WW; Novak, PJ; Faison, W; Binz, JG; Hashim, MA; Oliver, WO; Brown, HR; Parks, DJ; Plunket, KD; Tong, WQ; Menius, JA; Adkison, K; Noble, SA; Willson, TM. (1999) A novel N-aryl tyrosine activator of peroxisome proliferator-activated receptor-gamma reverses the diabetic phenotype of the Zucker diabetic fatty rat.
Diabetes, 48 (7): 1415-24.
[PMID:10389847]
11. Brown, PJ; Stuart, LW; Hurley, KP; Lewis, MC; Winegar, DA; Wilson, JG; Wilkison, WO; Ittoop, OR; Willson, TM. (2001) Identification of a subtype selective human PPARalpha agonist through parallel-array synthesis.
Bioorg. Med. Chem. Lett., 11 (9): 1225-7.
[PMID:11354382]
12. Carley, AN; Semeniuk, LM; Shimoni, Y; Aasum, E; Larsen, TS; Berger, JP; Severson, DL. (2004) Treatment of type 2 diabetic db/db mice with a novel PPARgamma agonist improves cardiac metabolism but not contractile function.
Am. J. Physiol. Endocrinol. Metab., 286 (3): E449-55.
[PMID:14600074]
13. Castillo, G; Brun, RP; Rosenfield, JK; Hauser, S; Park, CW; Troy, AE; Wright, ME; Spiegelman, BM. (1999) An adipogenic cofactor bound by the differentiation domain of PPARgamma.
EMBO J., 18 (13): 3676-87.
[PMID:10393183]
14. Cesario, RM; Klausing, K; Razzaghi, H; Crombie, D; Rungta, D; Heyman, RA; Lala, DS. (2001) The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Mol. Endocrinol., 15 (8): 1360-9.
[PMID:11463859]
15. Cesario, RM; Stone, J; Yen, WC; Bissonnette, RP; Lamph, WW. (2006) Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.
Cancer Lett., 240 (2): 225-33.
[PMID:16271436]
16. Chakrabarti, R; Misra, P; Vikramadithyan, RK; Premkumar, M; Hiriyan, J; Datla, SR; Damarla, RK; Suresh, J; Rajagopalan, R. (2004) Antidiabetic and hypolipidemic potential of DRF 2519--a dual activator of PPAR-alpha and PPAR-gamma.
Eur. J. Pharmacol., 491 (2-3): 195-206.
[PMID:15140637]
17. Chakrabarti, R; Vikramadithyan, RK; Misra, P; Hiriyan, J; Raichur, S; Damarla, RK; Gershome, C; Suresh, J; Rajagopalan, R. (2003) Ragaglitazar: a novel PPAR alpha PPAR gamma agonist with potent lipid-lowering and insulin-sensitizing efficacy in animal models.
Br. J. Pharmacol., 140 (3): 527-37.
[PMID:12970088]
18. Cheung, L; Messina, M; Gill, A; Clarkson, A; Learoyd, D; Delbridge, L; Wentworth, J; Philips, J; Clifton-Bligh, R; Robinson, BG. (2003) Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
J. Clin. Endocrinol. Metab., 88 (1): 354-7.
[PMID:12519876]
19. Cobb, JE; Blanchard, SG; Boswell, EG; Brown, KK; Charifson, PS; Cooper, JP; Collins, JL; Dezube, M; Henke, BR; Hull-Ryde, EA; Lake, DH; Lenhard, JM; Oliver, W; Oplinger, J; Pentti, M; Parks, DJ; Plunket, KD; Tong, WQ. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent.
J. Med. Chem., 41 (25): 5055-69.
[PMID:9836622]
20. Debril, MB; Dubuquoy, L; Feige, JN; Wahli, W; Desvergne, B; Auwerx, J; Gelman, L. (2005) Scaffold attachment factor B1 directly interacts with nuclear receptors in living cells and represses transcriptional activity.
J. Mol. Endocrinol., 35 (3): 503-17.
[PMID:16326836]
21. Debril, MB; Gelman, L; Fayard, E; Annicotte, JS; Rocchi, S; Auwerx, J. (2004) Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit.
J. Biol. Chem., 279 (16): 16677-86.
[PMID:14701856]
22. Deeb, SS; Fajas, L; Nemoto, M; Pihlajamäki, J; Mykkänen, L; Kuusisto, J; Laakso, M; Fujimoto, W; Auwerx, J. (1998) A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.
Nat. Genet., 20 (3): 284-7.
[PMID:9806549]
23. Desvergne, B; Michalik, L; Wahli, W. (2004) Be fit or be sick: peroxisome proliferator-activated receptors are down the road.
Mol. Endocrinol., 18 (6): 1321-32.
[PMID:15087471]
24. Desvergne, B; Wahli, W. (1999) Peroxisome proliferator-activated receptors: nuclear control of metabolism.
Endocr. Rev., 20 (5): 649-88.
[PMID:10529898]
25. Doebber, TW; Kelly, LJ; Zhou, G; Meurer, R; Biswas, C; Li, Y; Wu, MS; Ippolito, MC; Chao, YS; Wang, PR; Wright, SD; Moller, DE; Berger, JP. (2004) MK-0767, a novel dual PPARalpha/gamma agonist, displays robust antihyperglycemic and hypolipidemic activities.
Biochem. Biophys. Res. Commun., 318 (2): 323-8.
[PMID:15120604]
26. Ebdrup, S; Pettersson, I; Rasmussen, HB; Deussen, HJ; Frost Jensen, A; Mortensen, SB; Fleckner, J; Pridal, L; Nygaard, L; Sauerberg, P. (2003) Synthesis and biological and structural characterization of the dual-acting peroxisome proliferator-activated receptor alpha/gamma agonist ragaglitazar.
J. Med. Chem., 46 (8): 1306-17.
[PMID:12672231]
27. Ek, J; Urhammer, SA; Sørensen, TI; Andersen, T; Auwerx, J; Pedersen, O. (1999) Homozygosity of the Pro12Ala variant of the peroxisome proliferation-activated receptor-gamma2 (PPAR-gamma2): divergent modulating effects on body mass index in obese and lean Caucasian men.
Diabetologia, 42 (7): 892-5.
[PMID:10440134]
28. Elbrecht, A; Chen, Y; Adams, A; Berger, J; Griffin, P; Klatt, T; Zhang, B; Menke, J; Zhou, G; Smith, RG; Moller, DE. (1999) L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand binding.
J. Biol. Chem., 274 (12): 7913-22.
[PMID:10075686]
29. Fajas, L; Auboeuf, D; Raspé, E; Schoonjans, K; Lefebvre, AM; Saladin, R; Najib, J; Laville, M; Fruchart, JC; Deeb, S; Vidal-Puig, A; Flier, J; Briggs, MR; Staels, B; Vidal, H; Auwerx, J. (1997) The organization, promoter analysis, and expression of the human PPARgamma gene.
J. Biol. Chem., 272 (30): 18779-89.
[PMID:9228052]
30. Fajas, L; Fruchart, JC; Auwerx, J. (1998) PPARgamma3 mRNA: a distinct PPARgamma mRNA subtype transcribed from an independent promoter.
FEBS Lett., 438 (1-2): 55-60.
[PMID:9821958]
31. Ferry, G; Bruneau, V; Beauverger, P; Goussard, M; Rodriguez, M; Lamamy, V; Dromaint, S; Canet, E; Galizzi, JP; Boutin, JA. (2001) Binding of prostaglandins to human PPARgamma: tool assessment and new natural ligands.
Eur. J. Pharmacol., 417 (1-2): 77-89.
[PMID:11301062]
32. Forman, BM. (2002) The antidiabetic agent LG100754 sensitizes cells to low concentrations of peroxisome proliferator-activated receptor gamma ligands.
J. Biol. Chem., 277 (15): 12503-6.
[PMID:11877384]
33. Freedman, BD; Lee, EJ; Park, Y; Jameson, JL. (2005) A dominant negative peroxisome proliferator-activated receptor-gamma knock-in mouse exhibits features of the metabolic syndrome.
J. Biol. Chem., 280 (17): 17118-25.
[PMID:15716267]
34. Frohnert, BI; Hui, TY; Bernlohr, DA. (1999) Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene.
J. Biol. Chem., 274 (7): 3970-7.
[PMID:9933587]
35. Gelman, L; Zhou, G; Fajas, L; Raspé, E; Fruchart, JC; Auwerx, J. (1999) p300 interacts with the N- and C-terminal part of PPARgamma2 in a ligand-independent and -dependent manner, respectively.
J. Biol. Chem., 274 (12): 7681-8.
[PMID:10075656]
36. Greene, ME; Blumberg, B; McBride, OW; Yi, HF; Kronquist, K; Kwan, K; Hsieh, L; Greene, G; Nimer, SD. (1995) Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.
Gene Expr., 4 (4-5): 281-99.
[PMID:7787419]
37. Guan, HP; Ishizuka, T; Chui, PC; Lehrke, M; Lazar, MA. (2005) Corepressors selectively control the transcriptional activity of PPARgamma in adipocytes.
Genes Dev., 19 (4): 453-61.
[PMID:15681609]
38. Guardiola-Diaz, HM; Rehnmark, S; Usuda, N; Albrektsen, T; Feltkamp, D; Gustafsson, JA; Alexson, SE. (1999) Rat peroxisome proliferator-activated receptors and brown adipose tissue function during cold acclimatization.
J. Biol. Chem., 274 (33): 23368-77.
[PMID:10438514]
39. Guo, Q; Sahoo, SP; Wang, PR; Milot, DP; Ippolito, MC; Wu, MS; Baffic, J; Biswas, C; Hernandez, M; Lam, MH; Sharma, N; Han, W; Kelly, LJ; MacNaul, KL; Zhou, G; Desai, R; Heck, JV; Doebber, TW; Berger, JP; Moller, DE; Sparrow, CP; Chao, YS; Wright, SD. (2004) A novel peroxisome proliferator-activated receptor alpha/gamma dual agonist demonstrates favorable effects on lipid homeostasis.
Endocrinology, 145 (4): 1640-8.
[PMID:14701675]
40. He, W; Barak, Y; Hevener, A; Olson, P; Liao, D; Le, J; Nelson, M; Ong, E; Olefsky, JM; Evans, RM. (2003) Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle.
Proc. Natl. Acad. Sci. U.S.A., 100 (26): 15712-7.
[PMID:14660788]
41. Heinlein, CA; Ting, HJ; Yeh, S; Chang, C. (1999) Identification of ARA70 as a ligand-enhanced coactivator for the peroxisome proliferator-activated receptor gamma.
J. Biol. Chem., 274 (23): 16147-52.
[PMID:10347167]
42. Henke, BR. (2004) Peroxisome proliferator-activated receptor alpha/gamma dual agonists for the treatment of type 2 diabetes.
J. Med. Chem., 47 (17): 4118-27.
[PMID:15293980]
43. Henke, BR; Blanchard, SG; Brackeen, MF; Brown, KK; Cobb, JE; Collins, JL; Harrington, WW; Hashim, MA; Hull-Ryde, EA; Kaldor, I; Kliewer, SA; Lake, DH; Leesnitzer, LM; Lehmann, JM; Lenhard, JM; Orband-Miller, LA; Miller, JF; Mook, RA; Noble, SA; Oliver, W; Parks, DJ; Plunket, KD; Szewczyk, JR; Willson, TM. (1998) N-(2-Benzoylphenyl)-L-tyrosine PPARgamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents.
J. Med. Chem., 41 (25): 5020-36.
[PMID:9836620]
44. Hevener, AL; He, W; Barak, Y; Le, J; Bandyopadhyay, G; Olson, P; Wilkes, J; Evans, RM; Olefsky, J. (2003) Muscle-specific Pparg deletion causes insulin resistance.
Nat. Med., 9 (12): 1491-7.
[PMID:14625542]
45. Hong, JH; Hwang, ES; McManus, MT; Amsterdam, A; Tian, Y; Kalmukova, R; Mueller, E; Benjamin, T; Spiegelman, BM; Sharp, PA; Hopkins, N; Yaffe, MB. (2005) TAZ, a transcriptional modulator of mesenchymal stem cell differentiation.
Science, 309 (5737): 1074-8.
[PMID:16099986]
46. Huss, JM; Kopp, RP; Kelly, DP. (2002) Peroxisome proliferator-activated receptor coactivator-1alpha (PGC-1alpha) coactivates the cardiac-enriched nuclear receptors estrogen-related receptor-alpha and -gamma. Identification of novel leucine-rich interaction motif within PGC-1alpha.
J. Biol. Chem., 277 (43): 40265-74.
[PMID:12181319]
47. Huss, JM; Torra, IP; Staels, B; Giguère, V; Kelly, DP. (2004) Estrogen-related receptor alpha directs peroxisome proliferator-activated receptor alpha signaling in the transcriptional control of energy metabolism in cardiac and skeletal muscle.
Mol. Cell. Biol., 24 (20): 9079-91.
[PMID:15456881]
48. Imai, T; Takakuwa, R; Marchand, S; Dentz, E; Bornert, JM; Messaddeq, N; Wendling, O; Mark, M; Desvergne, B; Wahli, W; Chambon, P; Metzger, D. (2004) Peroxisome proliferator-activated receptor gamma is required in mature white and brown adipocytes for their survival in the mouse.
Proc. Natl. Acad. Sci. U.S.A., 101 (13): 4543-7.
[PMID:15070754]
49. Jackson, TA; Richer, JK; Bain, DL; Takimoto, GS; Tung, L; Horwitz, KB. (1997) The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
Mol. Endocrinol., 11 (6): 693-705.
[PMID:9171233]
50. Jaradat, MS; Wongsud, B; Phornchirasilp, S; Rangwala, SM; Shams, G; Sutton, M; Romstedt, KJ; Noonan, DJ; Feller, DR. (2001) Activation of peroxisome proliferator-activated receptor isoforms and inhibition of prostaglandin H(2) synthases by ibuprofen, naproxen, and indomethacin.
Biochem. Pharmacol., 62 (12): 1587-95.
[PMID:11755111]
51. Kamei, Y; Ohizumi, H; Fujitani, Y; Nemoto, T; Tanaka, T; Takahashi, N; Kawada, T; Miyoshi, M; Ezaki, O; Kakizuka, A. (2003) PPARgamma coactivator 1beta/ERR ligand 1 is an ERR protein ligand, whose expression induces a high-energy expenditure and antagonizes obesity.
Proc. Natl. Acad. Sci. U.S.A., 100 (21): 12378-83.
[PMID:14530391]
52. Kersten, S; Desvergne, B; Wahli, W. (2000) Roles of PPARs in health and disease.
Nature, 405 (6785): 421-4.
[PMID:10839530]
53. Kim, E; Chen, F; Wang, CC; Harrison, LE. (2006) CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation.
Int. J. Oncol., 28 (1): 191-4.
[PMID:16327995]
54. Kliewer, SA; Lenhard, JM; Willson, TM; Patel, I; Morris, DC; Lehmann, JM. (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation.
Cell, 83 (5): 813-9.
[PMID:8521498]
55. Kliewer, SA; Sundseth, SS; Jones, SA; Brown, PJ; Wisely, GB; Koble, CS; Devchand, P; Wahli, W; Willson, TM; Lenhard, JM; Lehmann, JM. (1997) Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma.
Proc. Natl. Acad. Sci. U.S.A., 94 (9): 4318-23.
[PMID:9113987]
56. Kliewer, SA; Umesono, K; Noonan, DJ; Heyman, RA; Evans, RM. (1992) Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors.
Nature, 358 (6389): 771-4.
[PMID:1324435]
57. Knutti, D; Kralli, A. (2001) PGC-1, a versatile coactivator.
Trends Endocrinol. Metab., 12 (8): 360-5.
[PMID:11551810]
58. Kodera, Y; Takeyama, K; Murayama, A; Suzawa, M; Masuhiro, Y; Kato, S. (2000) Ligand type-specific interactions of peroxisome proliferator-activated receptor gamma with transcriptional coactivators.
J. Biol. Chem., 275 (43): 33201-4.
[PMID:10944516]
59. Kojo, H; Fukagawa, M; Tajima, K; Suzuki, A; Fujimura, T; Aramori, I; Hayashi, K; Nishimura, S. (2003) Evaluation of human peroxisome proliferator-activated receptor (PPAR) subtype selectivity of a variety of anti-inflammatory drugs based on a novel assay for PPAR delta(beta).
J. Pharmacol. Sci., 93 (3): 347-55.
[PMID:14646253]
60. Koutnikova, H; Cock, TA; Watanabe, M; Houten, SM; Champy, MF; Dierich, A; Auwerx, J. (2003) Compensation by the muscle limits the metabolic consequences of lipodystrophy in PPAR gamma hypomorphic mice.
Proc. Natl. Acad. Sci. U.S.A., 100 (24): 14457-62.
[PMID:14603033]
61. Kubota, N; Terauchi, Y; Miki, H; Tamemoto, H; Yamauchi, T; Komeda, K; Satoh, S; Nakano, R; Ishii, C; Sugiyama, T; Eto, K; Tsubamoto, Y; Okuno, A; Murakami, K; Sekihara, H; Hasegawa, G; Naito, M; Toyoshima, Y; Tanaka, S; Shiota, K; Kitamura, T; Fujita, T; Ezaki, O; Aizawa, S; Kadowaki, T. (1999) PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance.
Mol. Cell, 4 (4): 597-609.
[PMID:10549291]
62. Laplante, M; Sell, H; MacNaul, KL; Richard, D; Berger, JP; Deshaies, Y. (2003) PPAR-gamma activation mediates adipose depot-specific effects on gene expression and lipoprotein lipase activity: mechanisms for modulation of postprandial lipemia and differential adipose accretion.
Diabetes, 52 (2): 291-9.
[PMID:12540599]
63. Lee, CH; Olson, P; Evans, RM. (2003) Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.
Endocrinology, 144 (6): 2201-7.
[PMID:12746275]
64. Leers, J; Treuter, E; Gustafsson, JA. (1998) Mechanistic principles in NR box-dependent interaction between nuclear hormone receptors and the coactivator TIF2.
Mol. Cell. Biol., 18 (10): 6001-13.
[PMID:9742117]
65. Lehmann, JM; Lenhard, JM; Oliver, BB; Ringold, GM; Kliewer, SA. (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other non-steroidal anti-inflammatory drugs.
J. Biol. Chem., 272 (6): 3406-10.
[PMID:9013583]
66. Lehmann, JM; Moore, LB; Smith-Oliver, TA; Wilkison, WO; Willson, TM; Kliewer, SA. (1995) An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma).
J. Biol. Chem., 270 (22): 12953-6.
[PMID:7768881]
67. Lemon, B; Inouye, C; King, DS; Tjian, R. (2001) Selectivity of chromatin-remodelling cofactors for ligand-activated transcription.
Nature, 414 (6866): 924-8.
[PMID:11780067]
68. Marques, AR; Espadinha, C; Catarino, AL; Moniz, S; Pereira, T; Sobrinho, LG; Leite, V. (2002) Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
J. Clin. Endocrinol. Metab., 87 (8): 3947-52.
[PMID:12161538]
69. Martin, G; Schoonjans, K; Lefebvre, AM; Staels, B; Auwerx, J. (1997) Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARalpha and PPARgamma activators.
J. Biol. Chem., 272 (45): 28210-7.
[PMID:9353271]
70. Misra, P; Chakrabarti, R; Vikramadithyan, RK; Bolusu, G; Juluri, S; Hiriyan, J; Gershome, C; Rajjak, A; Kashireddy, P; Yu, S; Surapureddi, S; Qi, C; Zhu, YJ; Rao, MS; Reddy, JK; Ramanujam, R. (2003) PAT5A: a partial agonist of peroxisome proliferator-activated receptor gamma is a potent antidiabetic thiazolidinedione yet weakly adipogenic.
J. Pharmacol. Exp. Ther., 306 (2): 763-71.
[PMID:12730351]
71. Mizukami, J; Taniguchi, T. (1997) The antidiabetic agent thiazolidinedione stimulates the interaction between PPAR gamma and CBP.
Biochem. Biophys. Res. Commun., 240 (1): 61-4.
[PMID:9367882]
72. Molnár, F; Matilainen, M; Carlberg, C. (2005) Structural determinants of the agonist-independent association of human peroxisome proliferator-activated receptors with coactivators.
J. Biol. Chem., 280 (28): 26543-56.
[PMID:15888456]
73. Mueller, E; Smith, M; Sarraf, P; Kroll, T; Aiyer, A; Kaufman, DS; Oh, W; Demetri, G; Figg, WD; Zhou, XP; Eng, C; Spiegelman, BM; Kantoff, PW. (2000) Effects of ligand activation of peroxisome proliferator-activated receptor gamma in human prostate cancer.
Proc. Natl. Acad. Sci. U.S.A., 97 (20): 10990-5.
[PMID:10984506]
74. Murakami, K; Ide, T; Suzuki, M; Mochizuki, T; Kadowaki, T. (1999) Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha.
Biochem. Biophys. Res. Commun., 260 (3): 609-13.
[PMID:10403814]
75. Murakami, K; Tobe, K; Ide, T; Mochizuki, T; Ohashi, M; Akanuma, Y; Yazaki, Y; Kadowaki, T. (1998) A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.
Diabetes, 47 (12): 1841-7.
[PMID:9836514]
76. Nichols, JS; Parks, DJ; Consler, TG; Blanchard, SG. (1998) Development of a scintillation proximity assay for peroxisome proliferator-activated receptor gamma ligand binding domain.
Anal. Biochem., 257 (2): 112-9.
[PMID:9514791]
77. Nikiforova, MN; Lynch, RA; Biddinger, PW; Alexander, EK; Dorn, GW; Tallini, G; Kroll, TG; Nikiforov, YE. (2003) RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
J. Clin. Endocrinol. Metab., 88 (5): 2318-26.
[PMID:12727991]
78. Norris, AW; Chen, L; Fisher, SJ; Szanto, I; Ristow, M; Jozsi, AC; Hirshman, MF; Rosen, ED; Goodyear, LJ; Gonzalez, FJ; Spiegelman, BM; Kahn, CR. (2003) Muscle-specific PPARgamma-deficient mice develop increased adiposity and insulin resistance but respond to thiazolidinediones.
J. Clin. Invest., 112 (4): 608-18.
[PMID:12925701]
79. Nosjean, O; Boutin, JA. (2002) Natural ligands of PPARgamma: are prostaglandin J(2) derivatives really playing the part?.
Cell. Signal., 14 (7): 573-83.
[PMID:11955950]
80. Oberfield, JL; Collins, JL; Holmes, CP; Goreham, DM; Cooper, JP; Cobb, JE; Lenhard, JM; Hull-Ryde, EA; Mohr, CP; Blanchard, SG; Parks, DJ; Moore, LB; Lehmann, JM; Plunket, K; Miller, AB; Milburn, MV; Kliewer, SA; Willson, TM. (1999) A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation.
Proc. Natl. Acad. Sci. U.S.A., 96 (11): 6102-6.
[PMID:10339548]
81. Oberkofler, H; Esterbauer, H; Linnemayr, V; Strosberg, AD; Krempler, F; Patsch, W. (2002) Peroxisome proliferator-activated receptor (PPAR) gamma coactivator-1 recruitment regulates PPAR subtype specificity.
J. Biol. Chem., 277 (19): 16750-7.
[PMID:11875072]
82. Pickavance, LC; Brand, CL; Wassermann, K; Wilding, JP. (2005) The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats.
Br. J. Pharmacol., 144 (3): 308-16.
[PMID:15655531]
83. Puigserver, P; Wu, Z; Park, CW; Graves, R; Wright, M; Spiegelman, BM. (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis.
Cell, 92 (6): 829-39.
[PMID:9529258]
84. Qi, C; Chang, J; Zhu, Y; Yeldandi, AV; Rao, SM; Zhu, YJ. (2002) Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha.
J. Biol. Chem., 277 (32): 28624-30.
[PMID:12039952]
85. Qi, C; Surapureddi, S; Zhu, YJ; Yu, S; Kashireddy, P; Rao, MS; Reddy, JK. (2003) Transcriptional coactivator PRIP, the peroxisome proliferator-activated receptor gamma (PPARgamma)-interacting protein, is required for PPARgamma-mediated adipogenesis.
J. Biol. Chem., 278 (28): 25281-4.
[PMID:12754253]
86. Qi, C; Zhu, Y; Reddy, JK. (2000) Peroxisome proliferator-activated receptors, coactivators, and downstream targets.
Cell Biochem. Biophys., 32 Spring: 187-204.
[PMID:11330046]
87. Reginato, MJ; Bailey, ST; Krakow, SL; Minami, C; Ishii, S; Tanaka, H; Lazar, MA. (1998) A potent antidiabetic thiazolidinedione with unique peroxisome proliferator-activated receptor gamma-activating properties.
J. Biol. Chem., 273 (49): 32679-84.
[PMID:9830009]
88. Ricote, M; Huang, J; Fajas, L; Li, A; Welch, J; Najib, J; Witztum, JL; Auwerx, J; Palinski, W; Glass, CK. (1998) Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein.
Proc. Natl. Acad. Sci. U.S.A., 95 (13): 7614-9.
[PMID:9636198]
89. Rocchi, S; Picard, F; Vamecq, J; Gelman, L; Potier, N; Zeyer, D; Dubuquoy, L; Bac, P; Champy, MF; Plunket, KD; Leesnitzer, LM; Blanchard, SG; Desreumaux, P; Moras, D; Renaud, JP; Auwerx, J. (2001) A unique PPARgamma ligand with potent insulin-sensitizing yet weak adipogenic activity.
Mol. Cell, 8 (4): 737-47.
[PMID:11684010]
90. Rosen, ED; Kulkarni, RN; Sarraf, P; Ozcan, U; Okada, T; Hsu, CH; Eisenman, D; Magnuson, MA; Gonzalez, FJ; Kahn, CR; Spiegelman, BM. (2003) Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.
Mol. Cell. Biol., 23 (20): 7222-9.
[PMID:14517292]
91. Rousseaux, C; Lefebvre, B; Dubuquoy, L; Lefebvre, P; Romano, O; Auwerx, J; Metzger, D; Wahli, W; Desvergne, B; Naccari, GC; Chavatte, P; Farce, A; Bulois, P; Cortot, A; Colombel, JF; Desreumaux, P. (2005) Intestinal antiinflammatory effect of 5-aminosalicylic acid is dependent on peroxisome proliferator-activated receptor-gamma.
J. Exp. Med., 201 (8): 1205-15.
[PMID:15824083]
92. Sabatino, L; Casamassimi, A; Peluso, G; Barone, MV; Capaccio, D; Migliore, C; Bonelli, P; Pedicini, A; Febbraro, A; Ciccodicola, A; Colantuoni, V. (2005) A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing.
J. Biol. Chem., 280 (28): 26517-25.
[PMID:15857827]
93. Sakamoto, J; Kimura, H; Moriyama, S; Imoto, H; Momose, Y; Odaka, H; Sawada, H. (2004) A novel oxyiminoalkanoic acid derivative, TAK-559, activates human peroxisome proliferator-activated receptor subtypes.
Eur. J. Pharmacol., 495 (1): 17-26.
[PMID:15219816]
94. Sakamoto, J; Kimura, H; Moriyama, S; Odaka, H; Momose, Y; Sugiyama, Y; Sawada, H. (2000) Activation of human peroxisome proliferator-activated receptor (PPAR) subtypes by pioglitazone.
Biochem. Biophys. Res. Commun., 278 (3): 704-11.
[PMID:11095972]
95. Sarraf, P; Mueller, E; Smith, WM; Wright, HM; Kum, JB; Aaltonen, LA; de la Chapelle, A; Spiegelman, BM; Eng, C. (1999) Loss-of-function mutations in PPAR gamma associated with human colon cancer.
Mol. Cell, 3 (6): 799-804.
[PMID:10394368]
96. Sasaki, T; Fujii, K; Yoshida, K; Shimura, H; Sasahira, T; Ohmori, H; Kuniyasu, H. (2006) Peritoneal metastasis inhibition by linoleic acid with activation of PPARgamma in human gastrointestinal cancer cells.
Virchows Arch., 448 (4): 422-7.
[PMID:16362414]
97. Schoonjans, K; Peinado-Onsurbe, J; Lefebvre, AM; Heyman, RA; Briggs, M; Deeb, S; Staels, B; Auwerx, J. (1996) PPARalpha and PPARgamma activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene.
EMBO J., 15 (19): 5336-48.
[PMID:8895578]
98. Schoonjans, K; Watanabe, M; Suzuki, H; Mahfoudi, A; Krey, G; Wahli, W; Grimaldi, P; Staels, B; Yamamoto, T; Auwerx, J. (1995) Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter.
J. Biol. Chem., 270 (33): 19269-76.
[PMID:7642600]
99. Sears, IB; MacGinnitie, MA; Kovacs, LG; Graves, RA. (1996) Differentiation-dependent expression of the brown adipocyte uncoupling protein gene: regulation by peroxisome proliferator-activated receptor gamma.
Mol. Cell. Biol., 16 (7): 3410-9.
[PMID:8668156]
100. Shao, W; Halachmi, S; Brown, M. (2002) ERAP140, a conserved tissue-specific nuclear receptor coactivator.
Mol. Cell. Biol., 22 (10): 3358-72.
[PMID:11971969]
101. Shibata, T; Matsui, K; Nagao, K; Shinkai, H; Yonemori, F; Wakitani, K. (1999) Pharmacological profiles of a novel oral antidiabetic agent, JTT-501, an isoxazolidinedione derivative.
Eur. J. Pharmacol., 364 (2-3): 211-9.
[PMID:9932726]
102. Soares, AF; Nosjean, O; Cozzone, D; D'Orazio, D; Becchi, M; Guichardant, M; Ferry, G; Boutin, JA; Lagarde, M; Géloën, A. (2005) Covalent binding of 15-deoxy-delta12,14-prostaglandin J2 to PPARgamma.
Biochem. Biophys. Res. Commun., 337 (2): 521-5.
[PMID:16198309]
103. Tien, ES; Davis, JW; Vanden Heuvel, JP. (2004) Identification of the CREB-binding protein/p300-interacting protein CITED2 as a peroxisome proliferator-activated receptor alpha coregulator.
J. Biol. Chem., 279 (23): 24053-63.
[PMID:15051727]
104. Tontonoz, P; Hu, E; Graves, RA; Budavari, AI; Spiegelman, BM. (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer.
Genes Dev., 8 (10): 1224-34.
[PMID:7926726]
105. Tontonoz, P; Hu, E; Spiegelman, BM. (1995) Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor gamma.
Curr. Opin. Genet. Dev., 5 (5): 571-6.
[PMID:8664544]
106. Treuter, E; Albrektsen, T; Johansson, L; Leers, J; Gustafsson, JA. (1998) A regulatory role for RIP140 in nuclear receptor activation.
Mol. Endocrinol., 12 (6): 864-81.
[PMID:9626662]
107. Valve, R; Sivenius, K; Miettinen, R; Pihlajamäki, J; Rissanen, A; Deeb, SS; Auwerx, J; Uusitupa, M; Laakso, M. (1999) Two polymorphisms in the peroxisome proliferator-activated receptor-gamma gene are associated with severe overweight among obese women.
J. Clin. Endocrinol. Metab., 84 (10): 3708-12.
[PMID:10523018]
108. Vikramadithyan, RK; Chakrabarti, R; Misra, P; Premkumar, M; Kumar, SK; Rao, CS; Ghosh, A; Reddy, KN; Uma, C; Rajagopalan, R. (2000) Euglycemic and hypolipidemic activity of PAT5A: a unique thiazolidinedione with weak peroxisome proliferator activated receptor gamma activity.
Metab. Clin. Exp., 49 (11): 1417-23.
[PMID:11092504]
109. Vu-Dac, N; Schoonjans, K; Kosykh, V; Dallongeville, J; Fruchart, JC; Staels, B; Auwerx, J. (1995) Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor.
J. Clin. Invest., 96 (2): 741-50.
[PMID:7635967]
110. Wang, Y; Porter, WW; Suh, N; Honda, T; Gribble, GW; Leesnitzer, LM; Plunket, KD; Mangelsdorf, DJ; Blanchard, SG; Willson, TM; Sporn, MB. (2000) A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma.
Mol. Endocrinol., 14 (10): 1550-6.
[PMID:11043571]
111. Welch, JS; Ricote, M; Akiyama, TE; Gonzalez, FJ; Glass, CK. (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages.
Proc. Natl. Acad. Sci. U.S.A., 100 (11): 6712-7.
[PMID:12740443]
112. Wright, HM; Clish, CB; Mikami, T; Hauser, S; Yanagi, K; Hiramatsu, R; Serhan, CN; Spiegelman, BM. (2000) A synthetic antagonist for the peroxisome proliferator-activated receptor gamma inhibits adipocyte differentiation.
J. Biol. Chem., 275 (3): 1873-7.
[PMID:10636887]
113. Xu, HE; Lambert, MH; Montana, VG; Plunket, KD; Moore, LB; Collins, JL; Oplinger, JA; Kliewer, SA; Gampe, RT; McKee, DD; Moore, JT; Willson, TM. (2001) Structural determinants of ligand binding selectivity between the peroxisome proliferator-activated receptors.
Proc. Natl. Acad. Sci. U.S.A., 98 (24): 13919-24.
[PMID:11698662]
114. Xu, Y; Rito, CJ; Etgen, GJ; Ardecky, RJ; Bean, JS; Bensch, WR; Bosley, JR; Broderick, CL; Brooks, DA; Dominianni, SJ; Hahn, PJ; Liu, S; Mais, DE; Montrose-Rafizadeh, C; Ogilvie, KM; Oldham, BA; Peters, M; Rungta, DK; Shuker, AJ; Stephenson, GA; Tripp, AE; Wilson, SB; Winneroski, LL; Zink, R; Kauffman, RF; McCarthy, JR. (2004) Design and synthesis of alpha-aryloxy-alpha-methylhydrocinnamic acids: a novel class of dual peroxisome proliferator-activated receptor alpha/gamma agonists.
J. Med. Chem., 47 (10): 2422-5.
[PMID:15115385]
115. Xue, B; Coulter, A; Rim, JS; Koza, RA; Kozak, LP. (2005) Transcriptional synergy and the regulation of Ucp1 during brown adipocyte induction in white fat depots.
Mol. Cell. Biol., 25 (18): 8311-22.
[PMID:16135818]
116. Yang, W; Rachez, C; Freedman, LP. (2000) Discrete roles for peroxisome proliferator-activated receptor gamma and retinoid X receptor in recruiting nuclear receptor coactivators.
Mol. Cell. Biol., 20 (21): 8008-17.
[PMID:11027271]
117. Young, PW; Buckle, DR; Cantello, BC; Chapman, H; Clapham, JC; Coyle, PJ; Haigh, D; Hindley, RM; Holder, JC; Kallender, H; Latter, AJ; Lawrie, KW; Mossakowska, D; Murphy, GJ; Roxbee Cox, L; Smith, SA. (1998) Identification of high-affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator-activated receptor gamma.
J. Pharmacol. Exp. Ther., 284 (2): 751-9.
[PMID:9454824]
118. Yu, C; Chen, L; Luo, H; Chen, J; Cheng, F; Gui, C; Zhang, R; Shen, J; Chen, K; Jiang, H; Shen, X. (2004) Binding analyses between Human PPARgamma-LBD and ligands.
Eur. J. Biochem., 271 (2): 386-97.
[PMID:14717706]
119. Yu, C; Markan, K; Temple, KA; Deplewski, D; Brady, MJ; Cohen, RN. (2005) The nuclear receptor corepressors NCoR and SMRT decrease peroxisome proliferator-activated receptor gamma transcriptional activity and repress 3T3-L1 adipogenesis.
J. Biol. Chem., 280 (14): 13600-5.
[PMID:15691842]
120. Yu, S; Matsusue, K; Kashireddy, P; Cao, WQ; Yeldandi, V; Yeldandi, AV; Rao, MS; Gonzalez, FJ; Reddy, JK. (2003) Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression.
J. Biol. Chem., 278 (1): 498-505.
[PMID:12401792]
121. Zamir, I; Harding, HP; Atkins, GB; Hörlein, A; Glass, CK; Rosenfeld, MG; Lazar, MA. (1996) A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.
Mol. Cell. Biol., 16 (10): 5458-65.
[PMID:8816459]
122. Zhou, G; Cummings, R; Li, Y; Mitra, S; Wilkinson, HA; Elbrecht, A; Hermes, JD; Schaeffer, JM; Smith, RG; Moller, DE. (1998) Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transfer.
Mol. Endocrinol., 12 (10): 1594-604.
[PMID:9773982]
123. Zhu, Y; Alvares, K; Huang, Q; Rao, MS; Reddy, JK. (1993) Cloning of a new member of the peroxisome proliferator-activated receptor gene family from mouse liver.
J. Biol. Chem., 268 (36): 26817-20.
[PMID:8262913]
124. Zhu, Y; Kan, L; Qi, C; Kanwar, YS; Yeldandi, AV; Rao, MS; Reddy, JK. (2000) Isolation and characterization of peroxisome proliferator-activated receptor (PPAR) interacting protein (PRIP) as a coactivator for PPAR.
J. Biol. Chem., 275 (18): 13510-6.
[PMID:10788465]
125. Zhu, Y; Qi, C; Cao, WQ; Yeldandi, AV; Rao, MS; Reddy, JK. (2001) Cloning and characterization of PIMT, a protein with a methyltransferase domain, which interacts with and enhances nuclear receptor coactivator PRIP function.
Proc. Natl. Acad. Sci. U.S.A., 98 (18): 10380-5.
[PMID:11517327]
126. Zhu, Y; Qi, C; Jain, S; Rao, MS; Reddy, JK. (1997) Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor.
J. Biol. Chem., 272 (41): 25500-6.
[PMID:9325263]
127. Zhu, Y; Qi, C; Korenberg, JR; Chen, XN; Noya, D; Rao, MS; Reddy, JK. (1995) Structural organization of mouse peroxisome proliferator-activated receptor gamma (mPPAR gamma) gene: alternative promoter use and different splicing yield two mPPAR gamma isoforms.
Proc. Natl. Acad. Sci. U.S.A., 92 (17): 7921-5.
[PMID:7644514]
Annotated and expert reviewed. Please contact us if you can help with updates.
